Polish billionaire investor Michal Solowow announced a tender offer for all shares of chemical company Synthos that he does not control, FTF Galleon, Synthos’ major shareholder, said late on October 26.
The intention is to ultimately delist the company from the Warsaw Stock Exchange. Solowow is offering PLN4.78 (€1.13) per share, roughly in line with last week’s closing price of PLN4.94.
The call is for 496.7mn shares. The potential value of the transaction is therefore over PLN2.24bn if the announced price stands.
The tender will last from November 17 until December 18. Solowow will consider a mandatory squeeze-out of shares if he secures at least a 90% stake. Solowow currently controls nearly 62.5% of Synthos.
Solowow told newspaper Puls Biznesu recently that Synthos’ dividend potential is likely to be limited in the coming years, due to high investments and maturing bonds, Wood notes.
“Moreover he claims that Synthos does not need any additional financing, so for the company, being public translates only into costs and disclosure requirements,” Wood analysts also said. They do not expect a solid interest in the tender at the proposed price, however.
Related Articles
Santander reportedly weighing sale options for its Polish unit
Banco Santander may offload part or all of its holding in Santander Bank Polska, people “familiar with the matter” told Bloomberg on April 8. The considerations come as Spain’s largest ... more
Poland’s Orlen signs deal to supply Ukraine with LNG
Ukraine’s Naftogaz will purchase 100mn cubic metres of LNG from Poland’s Orlen, Ukraine’s biggest state-owned energy firm announced on March 7. The LNG will be transported from cargoes ... more
Polish company Hynfra plans $1.6bn green ammonia plant in Egypt
Polish firm Hynfra has announced plans to establish a $1.6bn plant in Egypt for the production of green ammonia, with the investment potentially rising to $10.6bn as operations expand, Al Mal ... more
Most Read
-
Indonesia expands military role in government, protesters clash with police in Jakarta
27 days ago
-
Serbian biotech Dren Bio sold to Sanofi for $1.9bn
28 days ago
-
Putin tells Russia's oligarchs that the return of Western business will not be easy or cheap
29 days ago
-
US sets six conditions for Iran talks in Trump letter to Supreme Leader
27 days ago
-
Serbian police reportedly use sonic cannon against protesters
1 month ago